• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
HIV / AIDS - Pipeline Review, Q1 2011 - Product Image

HIV / AIDS - Pipeline Review, Q1 2011

  • ID: 1574033
  • February 2011
  • 355 pages
  • Global Markets Direct

HIV / AIDS - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, Q1 2011', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information on the therapeutic development for HIV / AIDS, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for HIV / AIDS. 'HIV / AIDS - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for HIV / AIDS.
- A review of the HIV / AIDS products under development by companies and universities/research institutes based on information derived from company and industry-specific READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
HIV / AIDS Overview
.Therapeutics Development
Therapeutics Development
An Overview of Pipeline Products for HIV / AIDS
HIV / AIDS Therapeutics under Development by Companies
HIV / AIDS Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Companies Involved in HIV / AIDS Therapeutics Development
Bristol-Myers Squibb Company
Johnson & Johnson
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Vical Incorporated
Valeant Pharmaceuticals International
GlaxoSmithKline plc
Nektar Therapeutics
Inovio Biomedical Corporation
Bavarian Nordic A/S
Endo Pharmaceuticals Holdings Inc.
Gilead Sciences, Inc.
Targeted Genetics Corporation
VIRxSYS Corporation
Merck & Co., Inc.
United Biomedical, Inc.
Lentigen Corporation
Myriad Genetics, Inc.
Sangamo BioSciences, Inc.
Cytokine PharmaSciences, Inc.
Generex Biotechnology Corporation
Nanotherapeutics, Inc.
Ambrilia Biopharma Inc.
Panacos Pharmaceuticals, Inc.
Biotron Limited
Aphios Corporation
Achillion Pharmaceuticals, Inc.
InterMune, Inc.
Japan Tobacco Inc.
Pfizer Inc.
Progenics Pharmaceuticals, Inc.
Avexa Limited
Koronis Pharmaceuticals, Inc.
Trimeris, Inc.
Astex Therapeutics Limited
Cyclacel Pharmaceuticals Inc.
Bayer AG
Inhibitex, Inc.
GeoVax Labs, Inc.
Hemispherx Biopharma, Inc.
Enzo Biochem, Inc.
Ardea Biosciences, Inc.
Medivir AB
Bio-Bridge Science, Inc.
Mymetics Corporation
NanoViricides, Inc.
Nutra Pharma Corporation
Peregrine Pharmaceuticals, Inc.
Pharmasset, Inc
CytoGenix, Inc.
CytRx Corporation
Starpharma Holdings Limited
Samaritan Pharmaceuticals, Inc.
BioAlliance Pharma SA
Eurocine Vaccines AB
Narhex Life Sciences Limited
Paloma Pharmaceuticals, Inc.
Affitech A/S
Aeras Global Tb Vaccine Foundation
AplaGen GmbH
Neorphys
Actis Biologics, Inc
BioMAS Ltd.
ViroStatics, srl
Argos Therapeutics, Inc.
Cytheris SA
Altor BioScience Corporation
Osel Inc.
AiCuris GmbH & Co. KG
Viroblock S.A.
AlphaVax, Inc.
ReProtect, Inc.
Sequoia Pharmaceuticals, Inc.
Rottapharm SpA
Xigen SA
Indus Biotech Private Limited
Presidio Pharmaceuticals, Inc.
Chimerix, Inc.
Theraclone Sciences, Inc.
Frontier Biotechnologies, Inc.
Viral Genetics, Inc.
Concert Pharmaceuticals, Inc.
Genexine Co., Ltd.
CytoDyn, Inc.
Oncolys BioPharma Inc.
PepTcell Limited
Arisyn Therapeutics Inc.
Tobira Therapeutics, Inc.
Genetic Immunity, LLC
Virax Holdings Limited
TNI Pharmaceuticals, Inc.
GenPhar, Inc.
Medisyn Technologies, Inc.
Pharis Biotec GmbH
FemmePharma Global Healthcare, Inc.
Amazon BioTech
ImQuest Pharmaceuticals, Inc.
CONRAD
ViiV Healthcare
RFS Pharma, LLC
Helix Therapeutics LLC
ImQuest Life Sciences
Du Pont de Nemours International SA
Universities/Institutes Involved in HIV / AIDS Therapeutics Development
HIV / AIDS - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Companies
1349572 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ampligen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cobicistat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Elvitegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Kaletra + Nevirapine + Two Nucleoside Transcriptase Inhibitors - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nelfinavir + Stavudine + Lamivudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PRO 2000/5 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Quad - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir + Kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SP-01A - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TMC278 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + TMC 278 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VGV-1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Viramune + Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Late Stage Drug Profiles – Universities/Institutes
(Lopinavir/Ritonavir) + Nucleoside Reverse Transcriptase Inhibitors + PEG-IFNa 2a + Ribavirin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Didanosine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Didanosine + Lopinavir/Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Efavirenz + Lamivudine + Lopinavir + Ritonavir + Nelfinavir + Nevirapine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Atazanavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir sulfate + Didanosine + Efavirenz + Lamivudine + Lopinavir/Ritonavir + Nevirapine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir/Lamivudine + Zidovudine + Nevirapine/Efavirenz/Nelfinavir/Lopinavir-Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Acyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Aldesleukin + ART - Drug Profile 177Product Description
Mechanism of Action
R&D Progress
Aluvia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Aluvia + Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ALVAC-HIV + AIDSVAX B/B - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Anti-HIV Immune Serum Globulin (Human) + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Anti-HIV Immune Serum Globulin (Human) + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
atazanavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Atazanavir + Didanosine + Efavirenz + Emtricitabine/Tenofovir disoproxil fumarate + Lamivudine + Lopinavir/Ritonavir + Nevirapine + Stavudine + Tenofovir disoproxil fumarate + Zidovudine/Lamivudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Atripla - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Buprenorphine + Naloxone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
chloroquine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Chloroquine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Clarithromycin + Ethambutol + Clofazimine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Clarithromycin + Ethambutol + Rifabutin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Darunavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Darunavir + Ritonavir + Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Didanosine + Abacavir + kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Didanosine + Lamivudine + Nevirapine + 2EHRZ3/4RH3 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Didanosine + Zalcitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz + Lamivudine + Tenofovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz + Lamivudine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz + Lamivudine + Zidovudine + Indinavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz + Stavudine + Lamivudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine + Tenofovir Disoproxil Fumarate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine + Tenofovir Disoproxil Fumarate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine + Tenofovir Disoproxil Fumarate + Lopinavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine + Tenofovir Disoproxil Fumarate + Lopinavir + Ritonavir + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine/Tenofovir + Darunavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine/Tenofovir + Lopinavir/Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Enfuvirtide + Raltegravir + Darunavir + Tipranavir + Etravirine + Maraviroc - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Engerix-B - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Erythromycin + Nevirapine + Ampicillin sodium + Metronidazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Etravirine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Fuzeon + Truvada + Kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GPO-VIR S + GPO-VIR Z - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GPO-VIR Z - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HAART + Isentress - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HAART + Isentress + Celsentri - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Highly Active Antiretroviral Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Indinavir + Ritonavir + Abacavir + Didanosine + Proleukin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Indinavir sulfate + Lamivudine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Intelence - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Interleukin-2 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Intravenous Gamma Globulin + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Isentress + Celsentri + Truvada + Kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Isoniazid + Cotrimoxazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Kaletra + Lamivudine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Kivexa - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lamivudine + Zidovudine + Nelfinavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lamivudine + Zidovudine + Nelfinavir + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Levocarnitine + Adefovir dipivoxil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lexiva + Norvir + Epzicom - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lopinavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
lopinavir + ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nelfinavir + Lamivudine + Zidovudine + Indinavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + AZT - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + HIV Immune Globulin Solution - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + Lopinavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + Rifampicin + Ethambutol + Isoniazid + Pyrazinamid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + Stavudine + Lamivudin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pegasys + Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pegylated Interferon Alfa-2a + Ribavirin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Prednisone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Prevenar + Pneumo23 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Anti-HIV Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Antiretroviral Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Paracetamol + Ibuprofen + Metoclopramide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Paracetamol + Ibuprofen + Metoclopramide + Codeine Phosphate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Paracetamol + Ibuprofen + Ondansetron - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Paracetamol + Ibuprofen + Ondansetron + Codeine Phosphate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir + Maraviroc + Emtricitabine/Tenofovir + Lopinavir/Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir + Maraviroc + Tenofovir + Emtricitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir + Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Remune + ALVAC(2)120(B,MN)GNP (vCP1452) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Reyataz + Isentress - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ritonavir + Atazanavir + Epzicom - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ritonavir + saquinavir + efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + Lamivudine + Abacavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Sustiva + Epzicom - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Sustiva + Kivexa - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tenofovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tenofovir + Emtricitabine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
tenofovir disoproxil fumarate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tenofovir Disoproxil Fumarate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tenofovir/Emtricitabine + Efavirenz + Maraviroc + Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Trimetrexate Glucuronate + Leucovorin Calcium - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Valacyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Valacyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Valsartan - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Viread - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Viread + Aluvia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zalcitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Immunoglobulin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Lamivudine + Abacavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Lamivudine + Kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Zalcitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Zalcitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ziodovudine + Alpha Interferon - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zovirax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Discontinued Products
HIV / AIDS - Featured News
1. Dec 13, 2010: Chimerix Reports Positive Phase I Results Of Antiviral CMX157
2. Dec 09, 2010: Argos Reports AGS-004 Shows Feasibility To Generate Fully Functional Dendritic Cells From Viremic Patients
3. Dec 06, 2010: GeoVax Expands Phase IIa Human HIV/AIDS Vaccine Trial
4. Nov 30, 2010: Argos Initiates Dosing Of Patients In Phase IIb HIV Clinical Trial Of Arcelis
5. Nov 29, 2010: GeoVax Labs' Strategy Supported By Encouraging Results Of European Therapeutic HIV/AIDS Vaccine Trial
6. Nov 23, 2010: Idenix Receives $20 Million Milestone Payment From ViiV Healthcare For Initiation Of Phase IIb Trial Of '761
7. Nov 18, 2010: Bionor Pharma's Vacc-4x Shows Statictically Significant Reduction In Viral Load In Phase IIb HIV Study
8. Nov 17, 2010: Inovio Pharmaceuticals' HIV DNA Vaccine Achieves Strong T-Cell Immune Responses In Phase I Human Trial
9. Nov 12, 2010: Inovio Pharmaceuticals To Present HIV Study Update At HVTN Conference
10. Nov 11, 2010: Theratechnologies Receives FDA Approval For EGRIFTA For Reduction Of Excess Abdominal Fat In HIV-Infected Patients With Lipodystrophy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for HIV / AIDS, 2011
Products under Development for HIV / AIDS – Comparative Analysis, 2011
Comparative Analysis by Late Stage Development, 2011
Comparative Analysis by Mid Clinical Stage Development, 2011
Comparative Analysis by Early Clinical Stage Development, 2011
Comparative Analysis by Discovery and Pre-Clinical Stage Development, 2011
Bristol-Myers Squibb Company, 2011
Johnson & Johnson, 2011
Boehringer Ingelheim GmbH, 2011
F. Hoffmann-La Roche Ltd., 2011
Abbott Laboratories, 2011
Vical Incorporated, 2011
Valeant Pharmaceuticals International, 2011
GlaxoSmithKline plc, 2011
Nektar Therapeutics, 2011
Inovio Biomedical Corporation, 2011
Bavarian Nordic A/S, 2011
Endo Pharmaceuticals Holdings Inc., 2011
Gilead Sciences, Inc., 2011
Targeted Genetics Corporation, 2011
VIRxSYS Corporation, 2011
Merck & Co., Inc., 2011
United Biomedical, Inc., 2011
Lentigen Corporation, 2011
Myriad Genetics, Inc., 2011
Sangamo BioSciences, Inc., 2011
Cytokine PharmaSciences, Inc., 2011
Generex Biotechnology Corporation, 2011
Nanotherapeutics, Inc., 2011
Ambrilia Biopharma Inc., 2011
Panacos Pharmaceuticals, Inc., 2011
Biotron Limited, 2011
Aphios Corporation, 2011
Achillion Pharmaceuticals, Inc., 2011
InterMune, Inc., 2011
Japan Tobacco Inc., 2011
Pfizer Inc., 2011
Progenics Pharmaceuticals, Inc., 2011
Avexa Limited, 2011
Koronis Pharmaceuticals, Inc., 2011
Trimeris, Inc., 2011
Astex Therapeutics Limited, 2011
Cyclacel Pharmaceuticals Inc., 2011
Bayer AG, 2011
Inhibitex, Inc., 2011
GeoVax Labs, Inc., 2011
Hemispherx Biopharma, Inc., 2011
Enzo Biochem, Inc., 2011
Ardea Biosciences, Inc., 2011
Medivir AB, 2011
Bio-Bridge Science, Inc., 2011
Mymetics Corporation, 2011
NanoViricides, Inc., 2011
Nutra Pharma Corporation, 2011
Peregrine Pharmaceuticals, Inc., 2011
Pharmasset, Inc, 2011
CytoGenix, Inc., 2011
CytRx Corporation, 2011
Starpharma Holdings Limited, 2011
Samaritan Pharmaceuticals, Inc., 2011
BioAlliance Pharma SA, 2011
Eurocine Vaccines AB, 2011
Narhex Life Sciences Limited, 2011
Paloma Pharmaceuticals, Inc., 2011
Affitech A/S, 2011
Aeras Global Tb Vaccine Foundation, 2011
AplaGen GmbH, 2011
Neorphys, 2011
Actis Biologics, Inc, 2011
BioMAS Ltd., 2011
ViroStatics, srl, 2011
Argos Therapeutics, Inc., 2011
Cytheris SA, 2011
Altor BioScience Corporation, 2011
Osel Inc., 2011
AiCuris GmbH & Co. KG, 2011
Viroblock S.A., 2011
AlphaVax, Inc., 2011
ReProtect, Inc., 2011
Sequoia Pharmaceuticals, Inc., 2011
Rottapharm SpA, 2011
Xigen SA, 2011
Indus Biotech Private Limited, 2011
Presidio Pharmaceuticals, Inc., 2011
Chimerix, Inc., 2011
Theraclone Sciences, Inc., 2011
Frontier Biotechnologies, Inc., 2011
Viral Genetics, Inc., 2011
Concert Pharmaceuticals, Inc., 2011
Genexine Co., Ltd., 2011
CytoDyn, Inc., 2011
Oncolys BioPharma Inc., 2011
PepTcell Limited, 2011
Arisyn Therapeutics Inc., 2011
Tobira Therapeutics, Inc., 2011
Genetic Immunity, LLC, 2011
Virax Holdings Limited, 2011
TNI Pharmaceuticals, Inc., 2011
GenPhar, Inc., 2011
Medisyn Technologies, Inc., 2011
Pharis Biotec GmbH, 2011
FemmePharma Global Healthcare, Inc., 2011
Amazon BioTech, 2011
ImQuest Pharmaceuticals, Inc., 2011
CONRAD, 2011
ViiV Healthcare, 2011
RFS Pharma, LLC, 2011
Helix Therapeutics LLC, 2011
ImQuest Life Sciences, 2011
Du Pont de Nemours International SA, 2011
Assessment by Monotherapy Products, 2011
Assessment by Combination Products
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Discontinued Products

List of Figures
Number of Products under Development for HIV / AIDS, 2011
Products under Development for HIV / AIDS – Comparative Analysis, 2011
Products under Development by Companies, 2011
Products under Investigation by Universities/Institutes, 2011
Late Stage Products, 2011
Mid Clinical Stage Products, 2011
Early Clinical Stage Products, 2011
Discovery and Pre-Clinical Stage Products, 2011
Assessment by Monotherapy Products, 2011
Assessment by Combination Products, 2011
Assessment by Route of Administration, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Assessment by Stage and Molecule Type, 2011

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos